Imperva (NYSE: IMPV) reported Q1 EPS of ($0.25), $0.03 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $59.8 million versus the consensus estimate of $59.62 million.

“We had a great start to the year driven by the ongoing demand for our best-of-breed discovery, protection and compliance solutions,” stated Anthony Bettencourt, President and Chief Executive Officer of Imperva. “During the first quarter, we were particularly pleased with the ongoing strong growth of our subscription revenue as well as deals over $100,000. We are confident in our ability to maintain the momentum for the remainder of the year given the growing need for enterprises to protect their business critical data and applications which has resulted in a strong pipeline of opportunities globally.”

GUIDANCE:

Imperva sees Q2 2016 EPS of ($0.02)-($0.04), versus the consensus of ($0.04). Imperva sees Q2 2016 revenue of $65.5-66.5 million, versus the consensus of $70.3 million.

Imperva sees FY2016 EPS of $0.23-$0.29. Imperva sees FY2016 revenue of $304-307 million.

For earnings history and earnings-related data on Imperva (IMPV) click here.